Rocket Pharmaceuticals in-27RCKTWPreferred / convertible
13F holders, Q1 2024 (March 31)15holders
1famous investor
$0.60avg. 13F price*
At the end of Q1 2024, 15 institutions reported holding Rocket Pharmaceuticals in-27 (RCKTW) in their 13F filings. The largest holders were Boothbay Fund Management, LLC ($994K), Altium Capital Management LLC ($219K) and Walleye Capital LLC ($216K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Rocket Pharmaceuticals in-27
- CUSIP
- 77313F114
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $219K |
| Exits | 1 | $11K |
Ownership 15 holders
| Boothbay Fund Management, LLC | — | No change | 36,912 | $994K |
| Altium Capital Management LLC | — | New | 731,561 | $219K |
| Walleye Capital LLC | — | Reduce 0.0% | 720,905 | $216K |
| Sio Capital Management, LLC | — | No change | 400,000 | $110K |
| Citadel Advisors | — | Add +21.5% | 364,823 | $109K |
| RTW Investments, LP | — | No change | 350,000 | $105K |
| Fort Baker Capital Management LP | — | No change | 328,698 | $98K |
| Silverarc Capital Management, LLC | — | No change | 104,828 | $31K |
| Affinity Asset Advisors, LLC | — | No change | 75,000 | $22K |
| LMR Partners LLP | — | No change | 60,771 | $18K |
| Pura Vida Investments, LLC | — | No change | 42,960 | $13K |
| Walleye Trading LLC | — | No change | 34,829 | $10K |
| Cowen and Company, LLC | — | Reduce -8.2% | 29,063 | $9K |
| Ancora Advisors LLC | — | No change | 6,000 | $2K |
| UBS Group AG | — | New | 99 | $30 |
"% of holder's portfolio" is RCKTW's weight in each manager's 13F, not the share of Rocket Pharmaceuticals in-27 the manager owns.